Search Results
Hollywood Cinematographer Climbing 12 Days for Cancer Cures
What happens when a group of nurses, doctors and cancer survivors of all ages come together to climb the highest mountain in Africa? History is made, and more importantly, lives are saved.
Lights, Camera, Action!
Stronger Together: Navigating Cancer as Newlyweds
As we round out our first year of marriage and our first year of battling cancer, I recently asked my husband Brad how he would describe this past year. “Disrupted.” Before cancer, we had plans: big, extravagant, travel-the-world kind of plans. After two years of a long-distance relationship, we were finally going to live in the same city. We were going to get settled in our brand-new home. We were going to make new Florida friends. We were excited about the opportunities we had in our careers. We were going to capitalize on the “newlywed phase” to the fullest extent!
Honoring Blood Cancer Survivors
Throughout June, in commemoration of #NationalCancerSurvivorMonth, we at LLS have been highlighting the resilience and achievements of blood cancer survivors. I’ve treated so many incredible young survivors in my years as a pediatric hematologist oncologist, and all of them hold a special place in my heart.
Nutrition Advice from a Dietitian & Blood Cancer Survivor
76-year-old Barbara Borrell is a woman who wears many hats – a 50+ year registered dietitian, nutrition consultant and educator, cancer advocate, volunteer with The Leukemia & Lymphoma Society, and a blood cancer survivor who has battled not one, not two, but three types of blood cancer.
Bold goal, bold action
As we observe World Cancer Day, I’m reflecting on my own family’s experience with blood cancer, the children with blood cancer I have had the honor of knowing, and the many individuals and families who have been impacted by a blood cancer diagnosis.
Our work at The Leukemia & Lymphoma Society (LLS) has had a positive impact on so many, but we can do even more to accelerate progress for the blood cancer patients we serve.
Work, School & Finances
Work and SchoolSome people continue to work or attend school through cancer treatment, but others are not able to do so. Talk to your healthcare team to know what to expect from treatment so you can make the decision that is best for you.
Bishoy
Born in Egypt, at the age of three, me and my family immigrated to the U.S. when I was diagnosed with acute lymphoblastic leukemia (ALL). I grew up in Long Island, New York, where I received treatment for 10 years. On my 13th birthday, I underwent brain surgery and remains cancer-free.
One More 'Ologist'
After staring down Stage IV non-Hodgkin lymphoma in 2016, I AM HERE, and I am grateful beyond measure. However, I am learning that the treatments that saved my life came at a high cost, and that in its own way survivorship is the hardest part of what I and my family now call, “the adventure.” 'The adventure' is certainly never what we imagined it would be.
Glenn
I was diagnosed with CLL in 2010 after feeling tired all the time, bruising easily, significant joint pain, a hot mess. I was told I could be treated but never cured. I survived an earlier cancer via radiation therapy where I was over radiated. I had never been so sick in all my life. While I don't ignore my condition I've decided to live best I can. I have a loving family and friends and a good career. I stay active as a volunteer firefighter (my way of giving back in honor of 911 victims as I was on the NYFD career list in 1999), home improvements, and attending family functions.
Ryan
I am a 12 year survivor of acute lymphoblastic leukemia (ALL) and was heavily involved with LLS when I was a patient going through treatment. I was a part of the Honored Hero program during elementary and middle school and would go speak and tell my story to schools in the Cincinnati Tri-State area with my mother.
Matthew
In 2014, I was diagnosed with Burkitt’s lymphoma, one of the most aggressive of all blood cancers and without quick action I would have had only 90 days to live. That was three years ago.
How Patients Really Feel About Artificial Intelligence in Healthcare
It seems that everywhere we turn lately we hear something about the promises and the perils of artificial intelligence (AI). AI is touted as a smart, efficient tool that can speed and streamline processes, analyze and manage complex data, and cut time and costs.
In the healthcare setting, it has the potential to be used to review and gather medical information quickly, screen for risk of disease and suggest diagnoses, provide second opinions, prevent harmful medication interactions, identify treatment options and clinical trials, reduce patient wait times, and much more.
Katie
Twenty years ago I did two things that shaped my life.
Dr. Brown
Jennifer Brown, M.D., Ph.D., who played a role in advancing ibrutinib for patients with chronic lymphocytic leukemia (CLL), is the recipient of an LLS Translational Research Program grant, and has previously received a career development program grant.
Her work is currently focused on studying the role that the Notch pathway plays in the development of CLL and whether therapies that target Notch can be effective for these patients.
Robert
I was diagnosed with acute myeloid leukemia (AML) when I was 18 years old the summer before I was supposed to start college. Instead, I spent six months receiving treatment on a clinical trial at CHOP. I was fortunate to have access to outstanding, cutting-edge cancer care and have a good outcome. This experience inspired me to pursue a career in medicine. I’m now a physician-scientist finishing my oncology fellowship at Dana-Farber Cancer Institution. I’m passionate about advancing the field of oncology through research and advocacy.
Lisa
It's not easy being bald, a bald physician, and a bald wife. This is my third dance with Hodgkin's Lymphoma (HL). I first met HL in college, as many young girls meet their first pivotal relationship. Sadly for me, I attended an all woman's college, so my pivotal 'boyfriend' came in the form of a first cancer diagnosis.
#ASH18: The Beat Goes On
On Sunday, I reported on a press briefing at the 60th ASH Annual Meeting where the preliminary findings of our Beat AML Master Clinical Trial were unveiled. This innovative collaborative study is designed to bring the hope of precision medicine to patients with acute myeloid leukemia (AML). (Read about our Friday ASH satellite symposium on immunotherapy here).
Dr. Wu
Catherine Wu, M.D., is focused on chronic lymphocytic leukemia (CLL). One aspect of her research is to gain greater understanding of the genetic underpinnings of CLL. She and her colleagues are studying the role that a mutated gene – SF3BL - plays in the development of CLL in order to develop improved strategies to treat CLL. Another focus on her lab is to develop an immunotherapy approach to treating CLL. She is working on employing a CLL-specific antigen to develop a personalized vaccine for patients with CLL. Dr.